2017

Permanent Rules: Promulgation Process Completed (Rules archive prior to 1996 is not complete)

Relating Clause

CR 17-089 (Text)

Relating to scheduling 4-Fluoroisobutyryl fentanyl
CR 17-088 (Text)

Relating to scheduling 5F-ADB, 5F-AMB, ADB-FUBINACA, MDMB-CHMICA, and MDMB-FUBINACA
CR 17-087 (Text)

Relating to scheduling 4-MePPP and a-PBP
CR 17-086 (Text)

Relating to scheduling MAB-CHMINACA
CR 17-085 (Text)

Relating to scheduling of AB-CHMINACA, AB-PINACA, and THJ-2201
CR 17-075 (Text)

Relating to scheduling cyclopropyl fentanyl.
CR 17-040 (Text)

Relating to scheduling acryl fentanyl.
CR 17-028 (Text)

Relating to the operation of the prescription drug monitoring program.
CR 17-023 (Text)

Relating to scheduling of AH-7921.
CR 17-022 (Text)

Relating to scheduling of eluxadoline.
CR 17-021 (Text)

Relating to scheduling of acetyl fentanyl.
CR 17-020 (Text)

Relating to scheduling of U-47700.
CR 17-009 (Text)

Relating to scheduling of brivaracetam.
CR 17-008 (Text)

Relating to scheduling of AB-FUBINACA and ADB-PINACA.
CR 17-007 (Text)

Relating to scheduling of thiafentanil.